Financial results for the twelve months ended December 31, 2022
Research and development expenses for the twelve months ended December 31, 2022, were $8 million, compared to $3.9 million in
Credo Technology Group (NASDAQ:CRDO) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.03 by 33.33 percent. The company reported quarterly sales of $51.40 million which